Hanmi Announces Merger While Possible Power Struggle Surfaces
OCI Alliance Good For Future Cash Flow?
An unexpected merger between Korea's Hanmi Pharm Group and chemical group OCI may raise eyebrows in terms of likely synergies, but analysts are viewing the planned transaction positively in terms of future cash flow. However, resistance from some members of Hanmi's founder family may mean a possible leadership struggle at the pharma company.
